X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7062) 7062
Book Review (1398) 1398
Publication (331) 331
Book Chapter (27) 27
Magazine Article (27) 27
Conference Proceeding (16) 16
Web Resource (6) 6
Book / eBook (4) 4
Dissertation (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6678) 6678
index medicus (6382) 6382
ticlopidine - analogs & derivatives (5720) 5720
ticlopidine - therapeutic use (5208) 5208
platelet aggregation inhibitors - therapeutic use (4716) 4716
male (3754) 3754
female (3376) 3376
middle aged (2895) 2895
aspirin - therapeutic use (2790) 2790
aged (2704) 2704
clopidogrel (2660) 2660
aspirin (2026) 2026
cardiac & cardiovascular systems (1848) 1848
treatment outcome (1802) 1802
drug therapy, combination (1527) 1527
ticlopidine - adverse effects (1447) 1447
abridged index medicus (1415) 1415
platelet aggregation inhibitors - adverse effects (1330) 1330
ticlopidine - administration & dosage (1249) 1249
risk factors (1132) 1132
percutaneous coronary intervention (1125) 1125
stents (1087) 1087
platelet aggregation inhibitors - administration & dosage (1054) 1054
peripheral vascular disease (1024) 1024
platelet aggregation - drug effects (931) 931
ticlopidine (912) 912
antiplatelet therapy (910) 910
adult (872) 872
pharmacology & pharmacy (827) 827
acute coronary syndromes (825) 825
ticlopidine - pharmacology (815) 815
hematology (808) 808
time factors (792) 792
platelet aggregation inhibitors - pharmacology (750) 750
risk (745) 745
myocardial-infarction (726) 726
prospective studies (725) 725
thrombosis (702) 702
medicine, general & internal (700) 700
aspirin - administration & dosage (698) 698
drug therapy (689) 689
aged, 80 and over (675) 675
acute coronary syndrome - drug therapy (670) 670
anticoagulants - therapeutic use (661) 661
stroke (639) 639
aspirin - adverse effects (630) 630
angioplasty, balloon, coronary (616) 616
therapy (604) 604
follow-up studies (598) 598
blood platelets - drug effects (584) 584
trial (566) 566
cardiology (564) 564
heart attacks (553) 553
myocardial infarction - drug therapy (548) 548
retrospective studies (548) 548
cardiovascular (533) 533
coronary heart disease (529) 529
care and treatment (524) 524
prevention (511) 511
hemorrhage - chemically induced (500) 500
blood platelets (486) 486
cardiac patients (485) 485
prasugrel (464) 464
fibrinolytic agents - therapeutic use (458) 458
randomized controlled trials as topic (458) 458
stroke - prevention & control (450) 450
mortality (448) 448
adenosine - analogs & derivatives (447) 447
intervention (445) 445
acute myocardial-infarction (441) 441
thiophenes - therapeutic use (432) 432
thrombosis - prevention & control (432) 432
platelet function tests (430) 430
animals (429) 429
surgery (419) 419
drug interactions (418) 418
prasugrel hydrochloride (413) 413
analysis (412) 412
angioplasty (412) 412
cardiovascular disease (408) 408
stent (399) 399
drug-eluting stents (397) 397
aggregation (396) 396
risk assessment (392) 392
secondary prevention (376) 376
drug resistance (375) 375
acute coronary syndrome (374) 374
clinical trials as topic (373) 373
coronary artery disease - drug therapy (373) 373
coronary angiography (371) 371
purinergic p2y receptor antagonists - therapeutic use (365) 365
medicine & public health (362) 362
double-blind method (359) 359
adenosine - therapeutic use (350) 350
platelets (350) 350
outcomes (345) 345
recurrence (344) 344
platelet reactivity (343) 343
st-segment elevation (343) 343
myocardial infarction - therapy (340) 340
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6368) 6368
German (181) 181
French (118) 118
Russian (90) 90
Spanish (85) 85
Chinese (58) 58
Italian (56) 56
Japanese (46) 46
Polish (20) 20
Dutch (16) 16
Turkish (13) 13
Hungarian (10) 10
Danish (7) 7
Portuguese (7) 7
Ukrainian (7) 7
Korean (6) 6
Finnish (5) 5
Hebrew (5) 5
Czech (2) 2
Lithuanian (2) 2
Norwegian (2) 2
Romanian (2) 2
Swedish (2) 2
Croatian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | TICLOPIDINE | WARFARIN | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | REGIMENS | NON-INFERIORITY TRIALS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 7, pp. 677 - 687
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
Journal Article